StreetAlpha.app
Home › Stocks › COO

Cooper Companies, Inc. (COO)

Healthcare
$58.88
▼ −2.40%
LAST CLOSE · NOV 20

Cooper makes contact lenses and women's health and fertility medical products for eye care providers and health care clinics. It last closed at $58.88 on Nov 20, down 2.40% on the day. The next earnings report for COO is expected around Thu, Dec 3, 2026, after the close. For the quarter ended Jul 2026, COO reported EPS of $2.24 on revenue of $1.07B, with revenue up 0.6% from a year ago. Over its last 8 reports the stock moved an average of 9.0% the session after earnings. Over the last 12 months COO insiders bought $3.2M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is COO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold COO.

Key Stats

Last 12 months
Results
Revenue
$4.2B
+4.7% vs a year ago
Net income
$570.3M
+39.8% vs a year ago
EPS (diluted)
$2.91
+42.6% vs a year ago
Free cash flow
$678.0M
16.0% margin
Valuation
Market cap
$11.2B
190.2M shares
P/E
20.2
Price over 12 month EPS
Price to sales
2.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$154.7M
At Jul 31
Debt
$2.5B
At Jul 31
Shareholder equity
$8.3B
Buybacks
$644.0M
Last 12 months
Fiscal year endsOctober
ExchangeNasdaq
Financials history
FY2021: $2.9B$2.9BFY2021FY2022: $3.3B$3.3BFY2022FY2023: $3.6B$3.6BFY2023FY2024: $3.9B$3.9BFY2024FY2025: $4.1B$4.1BFY2025

From COO's SEC filings, latest 10-Q for the period ending Jul 31, 2026 (filed Sep 9). Last 12 months adds up the four latest quarters.

Next report
Dec 3
Estimated date · After the close
Reported EPS
$2.24
Quarter ended Jul 2026
Year ago EPS
$0.49
+357.1% on a GAAP basis
Revenue
$1.07B
+0.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Oct 2024: $0.59Oct '24Jan 2025: $0.52Jan '25Apr 2025: $0.44Apr '25Jul 2025: $0.49Jul '25Oct 2025: $0.42Oct '25Jan 2026: $0.66Jan '26Apr 2026: -$0.40Apr '26Jul 2026: $2.24Jul '26Latest $2.24
Revenue by quarter
Oct 2024: $1.02BOct '24Jan 2025: $964.7MJan '25Apr 2025: $1.00BApr '25Jul 2025: $1.06BJul '25Oct 2025: $1.07BOct '25Jan 2026: $1.02BJan '26Apr 2026: $1.08BApr '26Jul 2026: $1.07BJul '26Latest $1.07B
How COO moved after its last 8 reports
Average move the session after a report ±9.0%
Sep 9, 2026After the close−14.7%
Jun 4, 2026After the close+8.6%
Mar 5, 2026After the close−4.5%
Dec 4, 2025After the close+5.7%
Aug 27, 2025After the close−12.8%
May 29, 2025After the close−14.6%
Mar 6, 2025After the close−6.6%
Dec 5, 2024After the close−4.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on COOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on COO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on COO

Technical Analysis

COO · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 15% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 42). The nearest support is the swing low (Oct 28) at $58.50, and the nearest resistance the Pivot at $59.51.

Short trendNeutral
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 2.9%/day
Key levels
$89.8352 week high+52.6%
$67.46200 day average+14.6%
$65.04100 day average+10.5%
$62.09Swing high (Oct 26)+5.5%
$61.5320 day average+4.5%
$60.35Pivot R1+2.5%
$59.51Pivot+1.1%
$58.88Last close
$58.50Swing low (Oct 28)−0.6%
$58.3650 day average−0.9%
$58.03Pivot S1−1.4%
$51.0152 week low−13.4%
Indicators
RSI (14)41.85Middle of its rangeNeutral
MACD0.28Below its signal lineBearish
Stochastic15.7Near the bottom of its rangeOversold
ADX (14)22.2Weak trend
Williams %R-96.8Oversold below −80, overbought above −20Oversold
CCI (20)-103.4Oversold below −100, overbought above 100Oversold
Rate of change−5.6%Change over 10 sessionsBearish
ATR (14)$1.68Typical daily range, 2.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Below
What happened before, for COO

What happened before

See how COO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow COO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How COO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for COOHow many large options trades hit COO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

COO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼292 buying vs 398 selling
  • ▼Held by funds -6.6 pts
  • ▼Funds holding -27
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding647674−4.0%
In funds' top 1079−22.2%
Held by funds103.7%110.3%−6.6 pts
New / increased99 / 193106 / 258−19.8%
Reduced / sold out277 / 121238 / 105+16.0%
Put/call ratio0.490.18+170.5%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See COO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

COO Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$3.2M9 buys · 7 insiders
Sold$00 sales · 0 insiders
Cluster buy: 3 insiders bought $1.9M between Sep 11 and Sep 16.
2025-12 bought $1.3M2026-09 bought $1.9MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 16Lawrence Erik KurziusDirectorBuy10,000$54.93$549K
Sep 14Walter M Rosebrough JrDirectorBuy10,000$54.16$542K
Sep 14Lawrence Erik KurziusDirectorBuy10,000$53.91$539K
Sep 11Paul A KeelDirectorBuy4,701$53.18$250K
Dec 22, 2025Cynthia L LuccheseDirectorBuy1,784$84.06$150K
Dec 18, 2025Maria RivasDirectorBuy1,000$82.13$82K
Every insider buy and sale for COO over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See COO insider trades →

From SEC Form 4 filings by COO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

COO Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$644.0M
5.8% yield
Left in program
$521.7M
4.7% of value
Shares outstanding, 12 months
−4.4%
Fewer shares
Last quarter
$339.0M
Jul 2026
Avg price paid, last quarter
$69.16
4.9M shares bought
S&P 500 rank by spending
#251 of 358
 
Spent each quarter, last 3 yearsTop bar $339.0M
Oct 2023: $0Jan 2024: $0Apr 2024: $0Jul 2024: $0Oct 2024: $0Jan 2025: $0Apr 2025: $40.6M, average price $75.60Jul 2025: $52.1M, average price $71.97Oct 2025: $197.3M, average price $67.48Jan 2026: $92.4M, average price $82.04Apr 2026: $13.2M, average price $75.84Jul 2026: $339.0M, average price $69.16
Oct 2023Jul 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Sep 9, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COO is in one of them and how their past COO trades turned out.

COO in the AI portfolios
Loading…

COO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered COO in an article yet. Here's the latest on the wider market.

COO in the news

COO Congress Trades

All congress trades →
Trades, 12 months
18
Buys
17
94%
Sells
1
6%
People
3
Last filed Nov 10
Who traded COO · since 2014
Latest 5 filings of 29
$1K – $15KTraded Oct 14, 2026Filed Nov 10, 2026
$1K – $15KTraded Oct 30, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 21, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 5, 2026Filed Nov 5, 2026
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KOct 14, 2026Nov 10, 202627 d
Ro KhannaD · CABuy$1K – $15KOct 30, 2026Nov 5, 20266 d
Ro KhannaD · CABuy$1K – $15KOct 21, 2026Nov 5, 202615 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KOct 5, 2026Nov 5, 202631 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Cooper Companies

Cooper is a medical device company based in San Ramon, California. Its CooperVision unit makes contact lenses for vision problems such as astigmatism and presbyopia, including lenses that slow nearsightedness in children. Its CooperSurgical unit sells fertility, women's health and cord blood storage products and services to clinics, obstetrician and gynecologist offices and hospitals. Its customers include eye care practitioners, retailers and health care providers worldwide.

Headquarters
San Ramon, CA
Founded
1958